Steven M. Paul, M.D.

Steven M. Paul, M.D.

Chair of the BoardatRapport Therapeutics· In proxies 2024–2025

Steven M. Paul, M.D. sits on 5 public boards.

Experience

  1. Rapport TherapeuticsPublic company · 2 yr
    • Chair of the Board2024 – Present · 2 yrStock in role +8%
  2. Neumarker Inc.Public company · 1 yr
    • Director2025 – Present · 1 yrNo stock prices for these years
  3. Seaport Therapeutics, Inc.Public company · 2 yr
    • Director2024 – Present · 2 yrNo stock prices for these years
  4. Sage Therapeutics, Inc.Public company · 13 yr
    • Director2011 – 2024 · 13 yrNo stock prices for these years
  5. Voyager Therapeutics, Inc.Public company · 8 yr
    • Director2014 – 2022 · 8 yrNo stock prices for these years
  6. Alnylam Pharmaceuticals, Inc.Public company · 12 yr
    • Director2010 – 2022 · 12 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?